Drug research

Docetaxel

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

Also recorded as Brand of drug is based on institutional procurement; Docecad; Taxotere

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL CancerNCT06463665	Genelux Corporation	Phase 2	Recruiting	2027-02Estimated
A Multinational, Randomized, Open-Label Study of Custirsen In Patients With Advanced or Metastatic (Stage IV) Non-Small Cell Lung CancerNCT01630733	Achieve Life Sciences	Phase 3	Completed	2016-11-17Actual
Aglatimagene Besadenovec + Prodrug and Pembrolizumab vs Docetaxel for Stage IV Non-Squamous NSCLC Progressing on Pembrolizumab (AURORA)NCT07660094	CADL	Phase 3	Recruiting	2031-10-22Estimated
A Phase III Study With THIO + Cemiplimab vs Chemotherapy as 3rd Line Treatment in Advanced/Metastatic NSCLCNCT06908304	Maia Biotechnology	Phase 3	Recruiting	2027-07-31Estimated
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast CancerNCT07102381	Jazz Pharmaceuticals	Phase 2	Recruiting	2028-01-01Estimated
Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint InNCT06745908	IBRX	Phase 3	Recruiting	2028-09Estimated

Genelux CorporationRecruitingPrimary completion: 2027-02 · Estimated

Trial details

Achieve Life SciencesCompletedPrimary completion: 2016-11-17 · Actual

Trial details

CADLRecruitingPrimary completion: 2031-10-22 · Estimated

Trial details

Maia BiotechnologyRecruitingPrimary completion: 2027-07-31 · Estimated

Trial details

Jazz PharmaceuticalsRecruitingPrimary completion: 2028-01-01 · Estimated

Trial details

IBRXRecruitingPrimary completion: 2028-09 · Estimated

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.